Unichem Laboratories Ltd. — Capital/Financing Update 2019

May 7, 2019

==> picture [177 x 40] intentionally omitted <==

May 7,2019

Department of Corporate Services

Bombay Stock Exchange, Towers, Dalal Street, Mumbai - 400 001.

Mr. Hari K.

Vice President - Operations National Exchange of India Ltd. Exchange Plaza, Complex, Bandra (East), Mumbai - 400 051.

Ref: BSE Scrip Code - 506690 NSE Symbol - UNICHEMLAB

Dear Sir,

Intimation under 30 of SEBI and Disclosure 2015.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the press release pertaining to receipt of tentative ANDA approval from USFDA for Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg (OTC)

For Unichem Laboratories Limited

==> picture [57 x 18] intentionally omitted <==

==> picture [75 x 28] intentionally omitted <==

==> picture [55 x 11] intentionally omitted <==

Thakore Head- Legal Company Secretary

==> picture [130 x 22] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. Tel.: +91 (22) 66 888 333 Fax.: +91 (22) 2678 4391 : www.unichemlabs.com :

==> picture [178 x 42] intentionally omitted <==

Mumbai, Tuesday, Nay 7,2019

PRESS RELEASE

Unichem Laboratories Limited is pleased to announce that it has received tentative ANDA approval from USFDA for Unichem's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg (OTC) to market a generic version of Johnson and Johnson Consumer Zyrtec-D 12 Hour (Cetirizine Hydrochloride, mg) Extended Tablets. These are indicated for:

1. Antihistamine

2. Nasal decongestant

The Product will be commercialized from on receipt of final approval.

About Unichem Laboratories Limited

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. In India, The Company has strong skills in product development, process chemistry and manufacturing complex API as well as dosage forms. More information about the Company can be found at www.unichemlabs.com

For more information please contact:

Ms. Thakore Ph: 404 E-mail: neema.thakore@unichemlabs.com

Disclaimer:

• • This press release includes forward looking statements. We have based these forward looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ serially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.

==> picture [131 x 23] intentionally omitted <==

Registered Office: Unichern Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. (22) 66 888 333 Fax.: +91 (22) 2678 4391 : CIN :